Is Eurofins Cerep SA halal to invest in?

According to Musaffa's Shariah screening methodology, Eurofins Cerep SA (ALECR.PA) is currently classified as DOUBTFUL as of February 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Eurofins Cerep SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Eurofins Cerep SA using these criteria to determine its compliance status.

Can Muslims buy shares of Eurofins Cerep SA?

Muslim investors may consider investing in Eurofins Cerep SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Eurofins Cerep SA classified as DOUBTFUL?

Musaffa determines the Shariah status of Eurofins Cerep SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Eurofins Cerep SA updated?

The Shariah compliance status of Eurofins Cerep SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Eurofins Cerep SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Eurofins Cerep SA?

You can check the latest Shariah compliance status of Eurofins Cerep SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Eurofins Cerep SA ALECR.PA

€15,900.00

Last Updated: May 04, 12:00 AM·XPAR

ALECR.PA Shariah Compliance

Screening Methodology: AAOIFI

DOUBTFUL

Last Updated: February 12, 2026

Report Source: 2025 2nd Quarter Report

Eurofins Cerep SA. Stock Analysis ALECR.PA

France Health Care Micro Cap Report: Q2, 2025

Eurofins-Cerep SA engages in the provision of preclinical drug research services. The company is headquartered in Celle-Levescault, Nouvelle-Aquitaine and currently employs 207 full-time employees. The company went IPO on 2010-03-19. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The firm then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. The Company’s maximum revenue is generated through Exports accounts.

Key Statistics of Eurofins Cerep SA (ALECR.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€15,900.00€15,900.00

Today's Open

€15,900.00

Volume

1.00

P/E Ratio (TTM)

11.21

52 Week Range

€15,400.00€18,900.00

Market Cap

80.21M

Avg. Volume

1.50

Dividend Yield

Financial Metrics & Statements of Eurofins Cerep SA (ALECR.PA)

FAQ's for Eurofins Cerep SA (ALECR.PA)

According to Musaffa’s Shariah screening methodology, Eurofins Cerep SA (ALECR.PA) is currently classified as DOUBTFUL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.